Core Points - The legal opinion letter confirms the legality of the convening and voting procedures of the second extraordinary general meeting of shareholders of Proris (Shanghai) Pharmaceutical Technology Development Co., Ltd. in 2025 [2][6] - The meeting was convened by the board of directors and held on July 21, 2025, with a combination of on-site and online voting [3][5] - The total number of shareholders present at the meeting was 126, representing 41,496,106 shares, which accounted for 52.1947% of the total shares [5] Meeting Procedures - The meeting was called by the board of directors and the notice was published on the Shenzhen Stock Exchange and other platforms on July 5, 2025 [3][5] - The meeting was held at the World Trade Center in Shanghai and was presided over by the chairman of Proris, Lai Chunbao [3][5] - Voting was conducted through both on-site and online methods, with specific time slots allocated for online voting [3][5] Voting Results - The first resolution regarding participation in the auction and establishment of real estate equity and corresponding debt was approved with 41,400,571 votes in favor, representing 99.7698% of the votes [6] - The second resolution concerning financial assistance to a proposed equity investment company was also approved with 41,374,691 votes in favor, representing 99.7074% of the votes [6] - The voting process was monitored and verified, ensuring compliance with legal and regulatory requirements [6]
普蕊斯: 北京国枫（上海）律师事务所关于普蕊斯（上海）医药科技开发股份有限公司2025第二次临时股东大会的法律意见书